Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism

R.E.G. Schutgens; E.U. Esseboom; R.J. Snijder; F.J. Haas; F. Verzijlbergen; H.K. Nieuwenhuis; J.A. Lisman; D.H. Biesma

Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism

Translated title of the contribution: Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism

R.E.G. Schutgens, E.U. Esseboom, R.J. Snijder, F.J. Haas, F. Verzijlbergen, H.K. Nieuwenhuis, J.A. Lisman, D.H. Biesma

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism
Original language	Undefined/Unknown
Pages (from-to)	100-107
Number of pages	8
Journal	Journal of Laboratory and Clinical Medicine
Volume	144
Publication status	Published - 2004

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Bescherming en bevordering van de menselijke gezondheid
Other medical specialities

Cite this

Schutgens, R. E. G., Esseboom, E. U., Snijder, R. J., Haas, F. J., Verzijlbergen, F., Nieuwenhuis, H. K., Lisman, J. A., & Biesma, D. H. (2004). Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism. Journal of Laboratory and Clinical Medicine, 144, 100-107.

@article{19b396691a1d4cb7bec25d7e9c635786,

title = "Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Bescherming en bevordering van de menselijke gezondheid, Other medical specialities",

author = "R.E.G. Schutgens and E.U. Esseboom and R.J. Snijder and F.J. Haas and F. Verzijlbergen and H.K. Nieuwenhuis and J.A. Lisman and D.H. Biesma",

year = "2004",

language = "Undefined/Unknown",

volume = "144",

pages = "100--107",

journal = "Journal of Laboratory and Clinical Medicine",

issn = "0022-2143",

publisher = "Mosby Inc.",

}

Schutgens, REG, Esseboom, EU, Snijder, RJ, Haas, FJ, Verzijlbergen, F, Nieuwenhuis, HK, Lisman, JA & Biesma, DH 2004, 'Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism', Journal of Laboratory and Clinical Medicine, vol. 144, pp. 100-107.

Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism. / Schutgens, R.E.G.; Esseboom, E.U.; Snijder, R.J. et al.
In: Journal of Laboratory and Clinical Medicine, Vol. 144, 2004, p. 100-107.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Low molecular weight heparin (dalteparin) is equally effective as unfractioned heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism

AU - Schutgens, R.E.G.

AU - Esseboom, E.U.

AU - Snijder, R.J.

AU - Haas, F.J.

AU - Verzijlbergen, F.

AU - Nieuwenhuis, H.K.

AU - Lisman, J.A.

AU - Biesma, D.H.

PY - 2004

Y1 - 2004

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Bescherming en bevordering van de menselijke gezondheid

KW - Other medical specialities

M3 - Article

SN - 0022-2143

VL - 144

SP - 100

EP - 107

JO - Journal of Laboratory and Clinical Medicine

JF - Journal of Laboratory and Clinical Medicine

ER -